Skip to main content
Top
Published in: Reactions Weekly 1/2016

01-10-2016 | Case report

Trientine

Neurological deterioration: case report

Published in: Reactions Weekly | Issue 1/2016

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literature
go back to reference Kleoniki C, et al. Clinical and imaging deterioration of a mild case of Wilson's disease after chelation therapy. Movement Disorders 31 (Suppl. 2): S223 abstr. 685, Jun 2016. Available from: URL: http://doi.org/10.1002/mds.26688 [abstract] -Greece Kleoniki C, et al. Clinical and imaging deterioration of a mild case of Wilson's disease after chelation therapy. Movement Disorders 31 (Suppl. 2): S223 abstr. 685, Jun 2016. Available from: URL: http://​doi.​org/​10.​1002/​mds.​26688 [abstract] -Greece
Metadata
Title
Trientine
Neurological deterioration: case report
Publication date
01-10-2016
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2016
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-21796-8

Other articles of this Issue 1/2016

Reactions Weekly 1/2016 Go to the issue

Case report

Apatinib

Case report

Ascorbic acid

Case report

Idelalisib

Case report

Interferon